These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14656418)

  • 61. Seroprevalence of antibody to varicella among Somali refugees.
    Nysse LJ; Pinsky NA; Bratberg JP; Babar-Weber AY; Samuel TT; Krych EH; Ziegler AW; Jimale MA; Vierkant RA; Jacobson RM; Poland GA
    Mayo Clin Proc; 2007 Feb; 82(2):175-80. PubMed ID: 17290724
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Seroprevalence of varicella-zoster virus in Korea.
    Choi WS; Noh JY; Huh JY; Jo YM; Lee J; Song JY; Kim WJ; Cheong HJ
    J Med Virol; 2010 Dec; 82(12):2123-6. PubMed ID: 20981803
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The seroepidemiology of the varicella-zoster virus in children and adolescents].
    Gil Miguel A; Lasheras Lozano ML; Jiménez García R; Calle Purón ME; Santos Santos M; Rey Calero J; Martín Hernández D
    Aten Primaria; 1993 May; 11(8):416-8. PubMed ID: 8388262
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population.
    van Rijckevorsel GG; Damen M; Sonder GJ; van der Loeff MF; van den Hoek A
    BMC Infect Dis; 2012 Jun; 12():140. PubMed ID: 22721551
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reliability of information on varicella history in preschool children.
    Bricks LF; Pannuti CS; Sato HK; Vico ES; de Faria AM; Souza VV; Sumita LM; Costa Ide C; Baldacci ER
    Clinics (Sao Paulo); 2007 Jun; 62(3):309-14. PubMed ID: 17589672
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus.
    Barbosa CM; Terreri MT; Rosário PO; de Moraes-Pinto MI; Silva CA; Hilário MO
    Clin Exp Rheumatol; 2012; 30(5):791-8. PubMed ID: 22935227
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A seroepidemiological study of Varicella-Zoster virus in Taipei City.
    Lin YJ; Huang LM; Lee CY; Chih TW; Lee PL; Chang LY; Hsu CM
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(1):11-5. PubMed ID: 8936004
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A seroepidemiology study of varicella among children aged 0-12 years in Taiwan.
    Tseng HF; Tan HF; Chang CK; Wang LY; Yang SE; Liau MY; Pan MJ; Chen CY; Huang SP
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1201-7. PubMed ID: 16438146
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Varicella zoster virus infection occurs at a relatively young age in The Netherlands.
    van Lier A; Smits G; Mollema L; Waaijenborg S; Berbers G; van der Klis F; Boot H; Wallinga J; de Melker H
    Vaccine; 2013 Oct; 31(44):5127-33. PubMed ID: 23973248
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Seroprevalence of varicella in the French population.
    Khoshnood B; Debruyne M; Lançon F; Emery C; Fagnani F; Durand I; Floret D
    Pediatr Infect Dis J; 2006 Jan; 25(1):41-4. PubMed ID: 16395101
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Seroepidemiology of varicella-zoster virus in Korea.
    Lee H; Cho HK; Kim KH
    J Korean Med Sci; 2013 Feb; 28(2):195-9. PubMed ID: 23400233
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Susceptibility to varicella-zoster virus in applicants for nurse training in Scotland.
    Waclawski ER; Stewart M
    Commun Dis Public Health; 2002 Sep; 5(3):240-2. PubMed ID: 12434695
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity.
    Heininger U; Braun-Fahrländer C; Desgrandchamps D; Glaus J; Grize L; Wutzler P; Schaad UB;
    Pediatr Infect Dis J; 2001 Aug; 20(8):775-8. PubMed ID: 11734740
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epidemiologic lessons: chickenpox outbreak investigation in a rural community around Chandigarh, North India.
    Singh MP; Singh G; Kumar A; Singh A; Ratho RK
    Indian J Pathol Microbiol; 2011; 54(4):772-4. PubMed ID: 22234108
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevalence of anti-varicella zoster IgG antibody in undergraduate students.
    Bhattarakosol P; Chantarabul S; Pittayathikhun K; Mung-mee V; Punnarugsa V
    Asian Pac J Allergy Immunol; 1996 Dec; 14(2):129-31. PubMed ID: 9177828
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
    Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
    Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Varicella-zoster virus antibody avidity and IgG-subclass patterns in children with recurrent chickenpox.
    Junker AK; Tilley P
    J Med Virol; 1994 Jun; 43(2):119-24. PubMed ID: 8083659
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Seroepidemiology of varicella-zoster virus in Bangladesh.
    Saha SK; Darmstadt GL; Hanif M; Khan R
    Ann Trop Paediatr; 2002 Dec; 22(4):341-5. PubMed ID: 12530284
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Varicella-zoster virus susceptibility and primary healthcare consultations in Norway.
    Rimseliene G; Vainio K; Gibory M; Salamanca BV; Flem E
    BMC Infect Dis; 2016 Jun; 16():254. PubMed ID: 27266273
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Screening healthcare workers for varicella-zoster virus: can we trust the history?
    Almuneef M; Memish ZA; Abbas ME; Balkhy HH
    Infect Control Hosp Epidemiol; 2004 Jul; 25(7):595-8. PubMed ID: 15301033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.